Lung Interstitial Macrophages Can Present Soluble Antigens and Induce Foxp3+ Regulatory T Cells
Céline Legrand,Domien Vanneste,Alexandre Hego,Catherine Sabatel,Kiréna Mollers,Joey Schyns,Pauline Maréchal,Joan Abinet,Amandine Tytgat,Maude Liégeois,Barbara Polese,Margot Meunier,Coraline Radermecker,Laurence Fiévez,Fabrice Bureau,Thomas Marichal
DOI: https://doi.org/10.1165/rcmb.2023-0254oc
IF: 7.748
2024-02-08
American Journal of Respiratory Cell and Molecular Biology
Abstract:Lung macrophages constitute a sophisticated surveillance and defense system that contributes to tissue homeostasis, host defense, and allows the host to cope with the myriad of insults and antigens to which the lung mucosa is exposed. As opposed to alveolar macrophages, lung interstitial macrophages express high levels of type 2 major histocompatibility complex (MHC-II), a hallmark of antigen-presenting cells. Here, we showed that lung IMs, like dendritic cells (DCs), possess the machinery to present soluble antigens in an MHC-II-restricted way. Using <i>ex vivo</i> ovalbumin (OVA)-specific T cell proliferation assays, we found that OVA-pulsed IMs could trigger OVA-specific CD4<sup>+</sup> T cell proliferation and Foxp3 expression via MHC-II-, IL-10 and Tgfβ-dependent mechanisms. Moreover, we showed that IMs efficiently captured locally instilled antigens <i>in vivo</i>, did not migrate to the draining lymph nodes and enhanced local interactions with CD4<sup>+</sup> T cells in a model of OVA-induced allergic asthma. These results support that IMs can present antigens to CD4<sup>+</sup> T cells and trigger regulatory T cells, which might attenuate lung immune responses and have functional consequences for lung immunity and T-cell-mediated disorders.
biochemistry & molecular biology,cell biology,respiratory system